These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9813289)

  • 1. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
    Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
    Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration.
    Sim-Selley LJ; Schechter NS; Rorrer WK; Dalton GD; Hernandez J; Martin BR; Selley DE
    Mol Pharmacol; 2006 Sep; 70(3):986-96. PubMed ID: 16760363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.
    Breivogel CS; Childers SR; Deadwyler SA; Hampson RE; Vogt LJ; Sim-Selley LJ
    J Neurochem; 1999 Dec; 73(6):2447-59. PubMed ID: 10582605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
    Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
    Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
    Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
    Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats.
    Di Marzo V; Berrendero F; Bisogno T; González S; Cavaliere P; Romero J; Cebeira M; Ramos JA; Fernández-Ruiz JJ
    J Neurochem; 2000 Apr; 74(4):1627-35. PubMed ID: 10737621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
    Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
    Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation.
    Selley DE; Rorrer WK; Breivogel CS; Zimmer AM; Zimmer A; Martin BR; Sim-Selley LJ
    J Neurochem; 2001 May; 77(4):1048-57. PubMed ID: 11359870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
    Carta G; Nava F; Gessa GL
    Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.
    García-Gil L; Romero J; Ramos JA; Fernández-Ruiz JJ
    Drug Alcohol Depend; 1999 Jun; 55(1-2):127-36. PubMed ID: 10402157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide.
    Kathmann M; Bauer U; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):421-7. PubMed ID: 10551279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940.
    Rubino T; Viganò D; Massi P; Parolaro D
    J Neurochem; 2000 Nov; 75(5):2080-6. PubMed ID: 11032897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPgammaS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide.
    Romero J; Berrendero F; García-Gil L; Lin SY; Makriyannis A; Ramos JA; Fernández-Ruiz JJ
    Neurochem Int; 1999 Jun; 34(6):473-82. PubMed ID: 10402222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.
    Dennis I; Whalley BJ; Stephens GJ
    Br J Pharmacol; 2008 Jul; 154(6):1349-58. PubMed ID: 18493244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of rat brain cannabinoid receptors after chronic morphine treatment.
    Rubino T; Tizzoni L; Viganò D; Massi P; Parolaro D
    Neuroreport; 1997 Oct; 8(15):3219-23. PubMed ID: 9351646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.